SABBY MANAGEMENT, LLC - VISTAGEN THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

VISTAGEN THERAPEUTICS INC's ticker is and the CUSIP is 92840H952. A total of 2 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,135,000
+191.8%
3,438
+9.7%
0.77%
+1231.0%
Q1 2022$389,000
-40.2%
3,135
-6.1%
0.06%
-38.9%
Q4 2021$651,000
+871.6%
3,337
+1267.6%
0.10%
+955.6%
Q3 2021$67,000–244–0.01%–
 Download
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders